I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 24% ± 9% | |
| epithelial cell | 6 studies | 35% ± 14% | |
| CD8-positive, alpha-beta T cell | 5 studies | 18% ± 1% | |
| natural killer cell | 5 studies | 22% ± 5% | |
| CD4-positive, alpha-beta T cell | 4 studies | 17% ± 2% | |
| plasmacytoid dendritic cell | 4 studies | 23% ± 4% | |
| classical monocyte | 3 studies | 24% ± 7% | |
| conventional dendritic cell | 3 studies | 30% ± 10% | |
| hematopoietic precursor cell | 3 studies | 27% ± 8% | |
| non-classical monocyte | 3 studies | 23% ± 5% | |
| B cell | 3 studies | 22% ± 7% | |
| fibroblast | 3 studies | 26% ± 8% | |
| ciliated cell | 3 studies | 30% ± 2% | |
| erythroblast | 3 studies | 32% ± 17% | |
| macrophage | 3 studies | 22% ± 5% | |
| dendritic cell | 3 studies | 34% ± 9% | |
| goblet cell | 3 studies | 20% ± 4% |
